SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

BTN Butn Limited

Financial Services · Credit Services · website
$0.01
52wk 0.01 – 0.10
Overall
38.0
Value
100.0
Growth
48.3
Health
22.2
Quality
0.0
Momentum
0.4
Dividend
—
Price
About Butn Limited

Butn Limited provides transactional funding to small and medium enterprises in Australia. The company offers funding solutions, such as Butn X, for cash up front against invoice or receivables, as well as invoice finance, debtor finance, selective invoice finance, and factoring; Butn Terms for outsource credit terms; and Butn Pay for paying invoice or bill in client's behalf. It also provides supply chain finance and commission advancement; and secured funding to new franchisees. In addition, the company is involved in private credit investment management activities. Butn Limited was founded in 2015 and is based in Balaclava, Australia.

Price analytics

Returns

1 day 0.0%
1 week 11.1%
1 month -9.1%
3 months -44.4%
6 months -67.7%
1 year -90.5%
3 years -92.9%

Risk

Volatility (1y ann.) 100.7%
Beta vs ASX 200 0.96
Sharpe (1y) -1.84
VaR 95% (1-day) -10.7%
Max drawdown (1y) -92.0%
Off 1-year high -90.0%

Technicals

RSI(14) 50
vs 50DMA -11.7%
vs 200DMA -67.8%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 100.0
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
—
Price / Book
100
Price / Sales
100
Growth 48.3
Revenue growth (1y)
42
Revenue CAGR (3y)
55
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 22.2
Net debt / EBITDA
0
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
0
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 0.4
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
2

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$3.82M
P/E (trailing)
—
P/E (forward)
-1.00
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
1.03
EV / EBITDA
—
Price / Book
0.33
ROE
-32.4%
Operating margin
-248.0%
Net margin
-67.6%
Total cash
$13.25M
Total debt
$83.87M
Current ratio
7.62
Debt / Equity
7.32
Free cash flow
—
Avg volume
525,314
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$15.27M
  • Gross profit$15.27M
  • Operating income$2.55M
  • Net income-$3.83M
  • Diluted EPS—
  • Free cash flow-$2.31M
  • Net debt$70.62M
Sector peers (Financial Services)
TickerMkt cap P/EScore
CBA $253.20B 23.3 38.2
NAB $117.86B 19.2 55.3
WBC $117.20B 16.9 45.3
ANZ $112.52B 19.0 56.2
MQG $93.62B 25.3 57.4
QBE $35.57B 11.6 80.1
CPU $23.13B 26.0 69.3
SUN $19.45B 19.3 52.7